| 1 | Intestinal Neoplasms | 54% |
| 2 | Stomach Neoplasms | 54% |
| 3 | Zollinger-Ellison syndrome | 49.9% |
| 4 | Colorectal Neoplasms | 45.3% |
| 5 | Cecal Neoplasms | 43.1% |
| 6 | Duodenal Neoplasms | 43.1% |
| 7 | Peritoneal Neoplasms | 38.2% |
| 8 | Appendiceal Neoplasms | 35.8% |
| 9 | Colonic Neoplasms | 35.8% |
| 10 | Rectal Neoplasms | 35.8% |
| 11 | Gastrointestinal Stromal Tumors | 35.1% |
| 12 | Pancreatic Neoplasm | 34.6% |
| 13 | Anus Neoplasms | 34.3% |
| 14 | Sigmoid Neoplasms | 34.3% |
| 15 | Liver neoplasms | 34.2% |
| 16 | Adenomatous Polyposis Coli | 34.1% |
| 17 | Esophagitis | 34.1% |
| 18 | Proctocolitis | 30.7% |
| 19 | Dysentery | 26.5% |
| 20 | Enteritis | 26.5% |
| 21 | Enterocolitis | 26.5% |
| 22 | Esophageal and Gastric Varices | 26.5% |
| 23 | Gastritis | 26.5% |
| 24 | Inflammatory Bowel Diseases | 26.5% |
| 25 | Barrett Esophagus | 26.3% |
| 26 | Esophageal Atresia | 25.9% |
| 27 | Duodenitis | 25.8% |
| 28 | Ileitis | 25.8% |
| 29 | Erosive Duodenitis | 25.8% |
| 30 | Bile Duct Neoplasms | 24.6% |
| 31 | gallbladder neoplasm | 24.6% |
| 32 | Esophageal Stenosis | 24.3% |
| 33 | Gastroenteritis | 23.5% |
| 34 | Intestinal Diseases | 23.5% |
| 35 | Stomach Diseases | 23.5% |
| 36 | Colitis | 23.1% |
| 37 | Duodenogastric Reflux | 23.1% |
| 38 | Peptic Ulcer | 23.1% |
| 39 | Proctitis | 23.1% |
| 40 | Hepatocellular Adenoma | 22% |
| 41 | Liver Neoplasms, Experimental | 21.9% |
| 42 | Parathyroid Neoplasms | 21.7% |
| 43 | Thyroid Neoplasm | 21.7% |
| 44 | Thyroid carcinoma | 21.7% |
| 45 | Esophageal Perforation | 21.5% |
| 46 | Pouchitis | 21.4% |
| 47 | Carcinoma, Pancreatic Ductal | 21.2% |
| 48 | Deglutition Disorders | 21.1% |
| 49 | Gastrointestinal Neoplasms | 20.3% |
| 50 | Appendicitis | 20.2% |
| 51 | Gastrointestinal Hemorrhage | 20.1% |
| 52 | Tuberculosis, Gastrointestinal | 19.9% |
| 53 | Crohn Disease | 19.7% |
| 54 | Duodenal Obstruction | 19.7% |
| 55 | Enterocolitis, Neutropenic | 19.7% |
| 56 | Necrotizing Enterocolitis | 19.7% |
| 57 | Rectal Fistula | 19.7% |
| 58 | Anal Fistula | 19.7% |
| 59 | Mesenteric vascular insufficiency | 19.4% |
| 60 | Tracheal Neoplasms | 19.4% |
| 61 | Intestinal Atresia | 19.2% |
| 62 | Mesenteric Vascular Occlusion | 19.2% |
| 63 | Esophageal Neoplasms | 19.2% |
| 64 | Intestinal Fistula | 19.2% |
| 65 | Enterocutaneous Fistula | 19.2% |
| 66 | Digestive System Neoplasms | 18.7% |
| 67 | Abdominal Neoplasms | 18.4% |
| 68 | Soft Tissue Neoplasms | 18.4% |
| 69 | Thoracic Neoplasms | 18.4% |
| 70 | Esophageal motility disorders | 18.1% |
| 71 | Mallory-Weiss Syndrome | 18.1% |
| 72 | Duodenal Ulcer | 18% |
| 73 | Peptic Ulcer Perforation | 18% |
| 74 | Gastric ulcer | 18% |
| 75 | Mouth Neoplasms | 17.7% |
| 76 | Enterocolitis, Pseudomembranous | 17.2% |
| 77 | pseudomembranous colitis | 17.2% |
| 78 | Dysentery, Bacillary | 17.2% |
| 79 | Biliary Tract Diseases | 17.1% |
| 80 | Liver diseases | 17.1% |
| 81 | Pancreatic Diseases | 17.1% |
| 82 | insulinoma | 17.1% |
| 83 | Gastrinoma | 17% |
| 84 | Glucagonoma | 17% |
| 85 | Vipoma | 16.5% |
| 86 | Endocrine Gland Neoplasms | 16.3% |
| 87 | Eye Neoplasms | 16.3% |
| 88 | Nervous System Neoplasms | 16.3% |
| 89 | Bone neoplasms | 15.9% |
| 90 | Skin Neoplasms | 15.9% |
| 91 | Colitis, Ischemic | 15.9% |
| 92 | Hematologic Neoplasms | 15.9% |
| 93 | Splenic Neoplasms | 15.8% |
| 94 | Colonic Pseudo-Obstruction | 15.5% |
| 95 | Cecal Diseases | 15.5% |
| 96 | Colonic Diseases | 15.5% |
| 97 | Ileal Diseases | 15.5% |
| 98 | Intestinal Obstruction | 15.5% |
| 99 | Intestinal Perforation | 15.5% |
| 100 | Jejunal Diseases | 15.5% |
| 101 | Pneumatosis Cystoides Intestinalis | 15.5% |
| 102 | Rectal Diseases | 15.5% |
| 103 | Gastric Dilatation | 15.5% |
| 104 | Gastric outlet obstruction | 15.5% |
| 105 | Cronkhite-Canada Syndrome | 15.5% |
| 106 | Intestinal Polyposis | 15.5% |
| 107 | Thyroid Nodule | 15.4% |
| 108 | Choledochal Cyst | 15.4% |
| 109 | Pancreatic Fistula | 15.1% |
| 110 | Esophageal Achalasia | 15.1% |
| 111 | Multiple Endocrine Neoplasia | 14.6% |
| 112 | Pancreatic Cyst | 14% |
| 113 | Intestinal Diseases, Parasitic | 13.7% |
| 114 | Paraneoplastic Encephalomyelitis | 13.5% |
| 115 | Esophageal Diseases | 13.4% |
| 116 | Mammary Neoplasms, Experimental | 13.3% |
| 117 | Achlorhydria | 13.3% |
| 118 | Gastric Antral Vascular Ectasia | 13.3% |
| 119 | Peptic Ulcer Hemorrhage | 13.2% |
| 120 | Gastroparesis | 13.2% |
| 121 | Biliary cirrhosis | 13% |
| 122 | Leukoplakia, Oral | 12.5% |
| 123 | Acanthoma | 12.3% |
| 124 | Nose Neoplasms | 11.8% |
| 125 | Peutz-Jeghers Syndrome | 11.8% |
| 126 | Laryngopharyngeal Reflux | 11.7% |
| 127 | Melena | 11.7% |
| 128 | Palatal Neoplasms | 11.6% |
| 129 | Retroperitoneal Neoplasms | 11.6% |
| 130 | Colonic Diseases, Functional | 11.5% |
| 131 | Fecal Incontinence | 11.5% |
| 132 | Fecal Impaction | 11.5% |
| 133 | Intussusception | 11.5% |
| 134 | Megacolon | 11.5% |
| 135 | Pyloric Stenosis | 11.5% |
| 136 | Ileus | 11.5% |
| 137 | Meconium ileus | 11.5% |
| 138 | Hematemesis | 11.5% |
| 139 | Cholecystolithiasis | 11.4% |
| 140 | Ear Neoplasms | 11.3% |
| 141 | Eyelid Neoplasms | 11.3% |
| 142 | Salivary Gland Neoplasms | 11.2% |
| 143 | Tongue Neoplasms | 11.2% |
| 144 | Carcinoma, Lobular | 10.9% |
| 145 | Testicular Neoplasms | 10.9% |
| 146 | Hamartoma | 10.9% |
| 147 | Neoplasms, Hormone-Dependent | 10.9% |
| 148 | Neoplasms, Multiple Primary | 10.9% |
| 149 | Paraneoplastic Syndromes | 10.9% |
| 150 | Precancerous Conditions | 10.9% |
| 151 | Neoplasms, Second Primary | 10.9% |
| 152 | Pharyngeal Neoplasms | 10.2% |
| 153 | Bile Duct Diseases | 10.1% |
| 154 | Cholelithiasis | 10.1% |
| 155 | Chylous Ascites | 10.1% |
| 156 | Fatty Liver | 10.1% |
| 157 | Hepatitis | 10.1% |
| 158 | Portal Hypertension | 10.1% |
| 159 | Liver Cirrhosis | 10.1% |
| 160 | Pancreatic Insufficiency | 10.1% |
| 161 | Pancreatitis | 10.1% |
| 162 | Pneumoperitoneum | 10.1% |
| 163 | Focal Nodular Hyperplasia | 10.1% |
| 164 | Hepatic Insufficiency | 10.1% |
| 165 | Steatohepatitis | 10.1% |
| 166 | Central Nervous System Neoplasms | 10% |
| 167 | Vascular Neoplasms | 10% |
| 168 | Thymus Neoplasms | 10% |
| 169 | Hemorrhoids | 10% |
| 170 | Genital Neoplasms, Female | 10% |
| 171 | Afferent Loop Syndrome | 9.9% |
| 172 | Celiac Disease | 9.9% |
| 173 | Short Bowel Syndrome | 9.9% |
| 174 | Sprue, Tropical | 9.9% |
| 175 | Steatorrhea | 9.9% |
| 176 | Rectocele | 9.9% |
| 177 | Sprue | 9.9% |
| 178 | Breast Neoplasms, Male | 9.9% |
| 179 | Choledocholithiasis | 9.9% |
| 180 | Triple Negative Breast Neoplasms | 9.9% |
| 181 | Fatty Liver, Alcoholic | 9.9% |
| 182 | Hepatitis, Alcoholic | 9.9% |
| 183 | Liver Cirrhosis, Alcoholic | 9.9% |
| 184 | Diverticulitis | 9.9% |
| 185 | Dumping Syndrome | 9.9% |
| 186 | Rectal Prolapse | 9.9% |
| 187 | Anal Fissure | 9.6% |
| 188 | Intestinal Pseudo-Obstruction | 9.6% |
| 189 | Irritable Bowel Syndrome | 9.6% |
| 190 | Superior Mesenteric Artery Syndrome | 9.6% |
| 191 | Neurogenic Bowel | 9.6% |
| 192 | Anal Ulcer | 9.6% |
| 193 | Multiple Endocrine Neoplasia Type 1 | 9.6% |
| 194 | Meningioma | 9.5% |
| 195 | Cyst | 9.4% |
| 196 | Neoplastic Processes | 9.4% |
| 197 | Neoplastic Syndromes, Hereditary | 9.4% |
| 198 | Pregnancy Complications, Neoplastic | 9.4% |
| 199 | Neoplasms, Experimental | 9.3% |
| 200 | Laryngeal neoplasm | 9.2% |
| 201 | Thymoma | 9.1% |
| 202 | Pancreatic Pseudocyst | 9% |
| 203 | Liver Diseases, Parasitic | 8.9% |
| 204 | Adrenal Gland Neoplasms | 8.9% |
| 205 | Genital Neoplasms, Male | 8.9% |
| 206 | Uveal Neoplasms | 8.9% |
| 207 | Giardiasis | 8.8% |
| 208 | Urologic Neoplasms | 8.8% |
| 209 | Acoustic Neuroma | 8.8% |
| 210 | Diverticulum | 8.7% |
| 211 | Sebaceous Gland Neoplasms | 8.7% |
| 212 | Spinal Neoplasms | 8.7% |
| 213 | Bone Marrow Neoplasms | 8.7% |
| 214 | Diverticulosis | 8.7% |
| 215 | Hepatic Veno-Occlusive Disease | 8.7% |
| 216 | Peliosis Hepatis | 8.7% |
| 217 | Hepatopulmonary Syndrome | 8.7% |
| 218 | Anus, Imperforate | 8.6% |
| 219 | Hemoperitoneum | 8.6% |
| 220 | Hepatomegaly | 8.6% |
| 221 | Mesenteric Panniculitis | 8.6% |
| 222 | Panniculitis, Peritoneal | 8.6% |
| 223 | Peritonitis | 8.6% |
| 224 | Peritoneal Fibrosis | 8.6% |
| 225 | Encapsulating Peritoneal Sclerosis | 8.6% |
| 226 | Anorectal Malformations | 8.6% |
| 227 | Biliary Fistula | 8.6% |
| 228 | Gastric Fistula | 8.6% |
| 229 | Hepatic Vein Thrombosis | 8.6% |
| 230 | Liver Abscess | 8.6% |
| 231 | Budd-Chiari Syndrome | 8.6% |
| 232 | Head and Neck Neoplasms | 8.4% |
| 233 | Carcinoma 256, Walker | 8.3% |
| 234 | Pruritus Ani | 8.2% |
| 235 | CREST Syndrome | 8.2% |
| 236 | Neoplasms, Radiation-Induced | 8.1% |
| 237 | Hypopharyngeal Neoplasms | 8.1% |
| 238 | Hypopharyngeal Cancer | 8.1% |
| 239 | Paraneoplastic Cerebellar Degeneration | 8.1% |
| 240 | Parotid Neoplasms | 8% |
| 241 | Liver Abscess, Amebic | 8% |
| 242 | Tuberous Sclerosis | 7.9% |
| 243 | Pituitary Adenoma | 7.8% |
| 244 | Pituitary Neoplasms | 7.8% |
| 245 | Retinoblastoma | 7.7% |
| 246 | Lactose Intolerance | 7.7% |
| 247 | Chemical and Drug Induced Liver Injury | 7.7% |
| 248 | Carcinoma, Ehrlich Tumor | 7.6% |
| 249 | Dermoid Cyst | 7.6% |
| 250 | Carcinoma, Lewis Lung | 7.6% |
| 251 | Nephroblastoma | 7.6% |
| 252 | Melanoma, Experimental | 7.6% |
| 253 | Trophoblastic Neoplasms | 7.5% |
| 254 | Hepatorenal Syndrome | 7.5% |
| 255 | Leukemia, Experimental | 7.5% |
| 256 | Limbic Encephalitis | 7.2% |
| 257 | Optic Nerve Glioma | 7.2% |
| 258 | Leydig Cell Tumor | 7.1% |
| 259 | Meningeal Neoplasms | 7.1% |
| 260 | Tonsillar Neoplasms | 7.1% |
| 261 | Neoplasms, Neuroepithelial | 7% |
| 262 | Gliomatosis cerebri | 7% |
| 263 | ovarian neoplasm | 7% |
| 264 | Cystic Fibrosis | 6.8% |
| 265 | Leukemia, Radiation-Induced | 6.7% |
| 266 | Porphyrias, Hepatic | 6.7% |
| 267 | Congenital Hyperinsulinism | 6.7% |
| 268 | Lambert-Eaton Myasthenic Syndrome | 6.7% |
| 269 | Nasopharyngeal carcinoma | 6.6% |
| 270 | Sarcoma, Experimental | 6.6% |
| 271 | Neuroectodermal Tumors | 6.6% |
| 272 | Cholangitis | 6.6% |
| 273 | Cholecystitis | 6.6% |
| 274 | Cholestasis | 6.6% |
| 275 | Common Bile Duct Diseases | 6.6% |
| 276 | Hepatitis, Chronic | 6.6% |
| 277 | Liver Failure | 6.6% |
| 278 | Pancreatitis, Chronic | 6.6% |
| 279 | Non-alcoholic Fatty Liver Disease | 6.6% |
| 280 | Chronic active hepatitis | 6.6% |
| 281 | Nasopharyngeal Neoplasms | 6.6% |
| 282 | Prolactinoma | 6.6% |
| 283 | Growth Hormone-Secreting Pituitary Adenoma | 6.6% |
| 284 | Medulloblastoma | 6.5% |
| 285 | Cryptosporidiosis | 6.4% |
| 286 | Lung Neoplasms | 6.3% |
| 287 | Pleural Neoplasms | 6.3% |
| 288 | Brain Neoplasms | 6.2% |
| 289 | Spinal Cord Neoplasms | 6.2% |
| 290 | melanoma | 6.1% |
| 291 | Uterine Neoplasms | 6.1% |
| 292 | Vaginal Neoplasms | 6.1% |
| 293 | Vulvar Neoplasms | 6.1% |
| 294 | Uterine Cancer | 6.1% |
| 295 | Erythroplasia | 6.1% |
| 296 | Follicular cyst | 6.1% |
| 297 | leukemia | 6.1% |
| 298 | Mucocele | 6.1% |
| 299 | Neoplasms, Germ Cell and Embryonal | 6.1% |
| 300 | Neoplasms, Glandular and Epithelial | 6.1% |
| 301 | Pilonidal Cyst | 6.1% |
| 302 | Thyroglossal Cyst | 6.1% |
| 303 | Synovial Cyst | 6.1% |
| 304 | Germ Cell Cancer | 6.1% |
| 305 | Aberrant Crypt Foci | 6.1% |
| 306 | Fallopian Tube Neoplasms | 6.1% |
| 307 | Opsoclonus-Myoclonus Syndrome | 6.1% |
| 308 | Paranasal Sinus Neoplasms | 6.1% |
| 309 | Hepatitis B, Chronic | 6% |
| 310 | Hepatitis C, Chronic | 6% |
| 311 | granulosa cell tumor | 5.9% |
| 312 | Carcinoma, Ovarian Epithelial | 5.9% |
| 313 | Hepatitis, Animal | 5.9% |
| 314 | Hepatitis, Viral, Human | 5.9% |
| 315 | Choriocarcinoma | 5.8% |
| 316 | Gastrointestinal Diseases | 5.7% |
| 317 | Liver Cirrhosis, Experimental | 5.7% |
| 318 | Carcinosarcoma | 5.7% |
| 319 | Hemangiosarcoma | 5.7% |
| 320 | Leukemia L1210 | 5.7% |
| 321 | Leukemia P388 | 5.7% |
| 322 | lymphangiosarcoma | 5.7% |
| 323 | Pancreatitis, Alcoholic | 5.7% |
| 324 | Mesoblastic Nephroma | 5.6% |
| 325 | Meningeal Carcinomatosis | 5.6% |
| 326 | Myelitis, Transverse | 5.6% |
| 327 | Central Nervous System Cysts | 5.6% |
| 328 | Penile Neoplasms | 5.5% |
| 329 | Prostatic Neoplasms | 5.5% |
| 330 | Lymphomatoid Granulomatosis | 5.5% |
| 331 | Polycythemia Vera | 5.5% |
| 332 | Basal Cell Nevus Syndrome | 5.4% |
| 333 | Leukoplakia | 5.3% |
| 334 | Lymphocele | 5.3% |
| 335 | Adenoma, Acidophil | 5.3% |
| 336 | Ganglioneuroma | 5.3% |
| 337 | Glioma | 5.3% |
| 338 | Malignant Glioma | 5.3% |
| 339 | Maxillary Sinus Neoplasms | 5.3% |
| 340 | Breast Cyst | 5.3% |
| 341 | Histiocytic Disorders, Malignant | 5.3% |
| 342 | Actinic keratosis | 5.3% |
| 343 | Mediastinal Cyst | 5.3% |
| 344 | Neoplasm Invasiveness | 5.3% |
| 345 | Neoplasm Metastasis | 5.3% |
| 346 | Neoplasm Recurrence, Local | 5.3% |
| 347 | Parovarian Cyst | 5.3% |
| 348 | Pericardial Cyst | 5.3% |
| 349 | Thymic Cyst | 5.3% |
| 350 | Carcinogenesis | 5.3% |
| 351 | Myxoid cyst | 5.3% |
| 352 | Metastasis | 5.3% |
| 353 | Adrenocortical carcinoma | 5.2% |
| 354 | Sarcoma 180 | 5.2% |
| 355 | Composite Lymphoma | 5.1% |
| 356 | Fascioliasis | 5% |
| 357 | Echinococcosis, Hepatic | 5% |
| 358 | Bronchial Neoplasms | 5% |
| 359 | Chemical and Drug Induced Liver Injury, Chronic | 5% |
| 360 | Reye Syndrome | 5% |
| 361 | Multiple Pulmonary Nodules | 4.9% |
| 362 | Cholestasis, Extrahepatic | 4.9% |
| 363 | Biliary Dyskinesia | 4.9% |
| 364 | Cholangitis, Sclerosing | 4.9% |
| 365 | Liver Failure, Acute | 4.9% |
| 366 | Acalculous Cholecystitis | 4.9% |
| 367 | End Stage Liver Disease | 4.9% |
| 368 | Leukemia, Plasma Cell | 4.9% |
| 369 | Bladder Neoplasm | 4.9% |
| 370 | Kidney Neoplasm | 4.9% |
| 371 | Ureteral Neoplasms | 4.9% |
| 372 | Urethral Neoplasms | 4.9% |
| 373 | Supratentorial Neoplasms | 4.9% |
| 374 | Carcinoid Tumor | 4.9% |
| 375 | Endometrial Neoplasms | 4.9% |
| 376 | Neurilemmoma | 4.9% |
| 377 | Hutchinson's Melanotic Freckle | 4.9% |
| 378 | Melanoma, Amelanotic | 4.9% |
| 379 | Renal Cell Carcinoma | 4.7% |
| 380 | Papillary Renal Cell Carcinoma | 4.7% |
| 381 | Basal cell carcinoma | 4.7% |
| 382 | Carcinoma, Papillary | 4.7% |
| 383 | Squamous cell carcinoma | 4.7% |
| 384 | Chondrosarcoma | 4.7% |
| 385 | Craniopharyngioma | 4.7% |
| 386 | Cystadenoma | 4.7% |
| 387 | leiomyosarcoma | 4.7% |
| 388 | liposarcoma | 4.7% |
| 389 | Mesothelioma | 4.7% |
| 390 | synovial sarcoma | 4.7% |
| 391 | Neuroectodermal Tumor, Melanotic | 4.7% |
| 392 | Angiomyolipoma | 4.7% |
| 393 | Clear Cell Sarcoma of Soft Tissue | 4.7% |
| 394 | Alveolar Soft Part Sarcoma | 4.7% |
| 395 | Neuroendocrine Tumors | 4.7% |
| 396 | Sarcoma, Myeloid | 4.7% |
| 397 | Carcinoma, Basal Cell | 4.7% |
| 398 | Lymphoma | 4.6% |
| 399 | Corpus Luteum Cyst | 4.6% |
| 400 | Ovarian Cysts | 4.6% |
| 401 | Astrocytoma | 4.5% |
| 402 | Ependymoma | 4.5% |
| 403 | oligodendroglioma | 4.5% |
| 404 | Ganglioglioma | 4.5% |
| 405 | gliosarcoma | 4.5% |
| 406 | Anaplastic astrocytoma | 4.5% |
| 407 | Anaplastic Oligodendroglioma | 4.5% |
| 408 | Pleural Effusion, Malignant | 4.4% |
| 409 | Nesidioblastosis | 4.4% |
| 410 | Variegate Porphyria | 4.4% |
| 411 | Acute intermittent porphyria | 4.4% |
| 412 | Porphyria Cutanea Tarda | 4.4% |
| 413 | Prostatic Neoplasms, Castration-Resistant | 4.4% |
| 414 | Nelson Syndrome | 4.3% |
| 415 | Autoimmune hepatitis | 4.3% |
| 416 | Denys-Drash Syndrome | 4.3% |
| 417 | Brain Stem Neoplasms | 4.3% |
| 418 | Malignant Carcinoid Syndrome | 4.3% |
| 419 | Carcinoma, Endometrioid | 4.3% |
| 420 | Cystadenocarcinoma | 4.2% |
| 421 | Fibrosarcoma | 4.2% |
| 422 | Osteosarcoma | 4.2% |
| 423 | Mucoepidermoid Carcinoma | 4.2% |
| 424 | Massive Hepatic Necrosis | 4.1% |
| 425 | Emphysematous Cholecystitis | 4.1% |
| 426 | Sphincter of Oddi Dysfunction | 4.1% |
| 427 | Glioblastoma | 4.1% |
| 428 | Neuroblastoma | 4.1% |
| 429 | Glioblastoma Multiforme | 4.1% |
| 430 | Endometrial Stromal Sarcoma | 4% |
| 431 | Adenofibroma | 4% |
| 432 | Fibroadenoma | 4% |
| 433 | Malignant Fibrous Histiocytoma | 4% |
| 434 | Choroid Plexus Papilloma | 4% |
| 435 | Zellweger Syndrome | 3.9% |
| 436 | Adenoma | 3.9% |
| 437 | Ameloblastoma | 3.9% |
| 438 | Angiokeratoma | 3.9% |
| 439 | Carcinoma | 3.9% |
| 440 | Chordoma | 3.9% |
| 441 | Hemangioma | 3.9% |
| 442 | hemangiopericytoma | 3.9% |
| 443 | Lymphangioma | 3.9% |
| 444 | Mesenchymoma | 3.9% |
| 445 | Nevus | 3.9% |
| 446 | Teratoma | 3.9% |
| 447 | Hepatoblastoma | 3.9% |
| 448 | Mixed Tumor, Mullerian | 3.9% |
| 449 | Germinoma | 3.9% |
| 450 | Teratocarcinoma | 3.9% |
| 451 | Angiofibroma | 3.9% |
| 452 | Sarcoma | 3.9% |
| 453 | Epithelioma | 3.9% |
| 454 | Ganglioneuroblastoma | 3.9% |
| 455 | Hepatitis, Viral, Animal | 3.8% |
| 456 | Cerebellar Neoplasms | 3.8% |
| 457 | Hepatitis E | 3.8% |
| 458 | Hepatitis B | 3.7% |
| 459 | Hepatitis C | 3.7% |
| 460 | Bowen's Disease | 3.7% |
| 461 | Paraganglioma | 3.7% |
| 462 | Rhabdomyosarcoma | 3.7% |
| 463 | Giant Cell Tumor of Bone | 3.7% |
| 464 | Hepatitis A | 3.7% |
| 465 | Neurofibrosarcoma | 3.7% |
| 466 | Hepatic Encephalopathy | 3.7% |
| 467 | Hepatolenticular Degeneration | 3.7% |
| 468 | Hydatidiform Mole | 3.7% |
| 469 | Lymphangioleiomyomatosis | 3.6% |
| 470 | Carcinoid Heart Disease | 3.6% |
| 471 | Dermatofibrosarcoma | 3.5% |
| 472 | Dermatofibrosarcoma Protuberans | 3.5% |
| 473 | Plasmacytoma | 3.3% |
| 474 | Malignant histiocytosis | 3.3% |
| 475 | Lymphatic Metastasis | 3.3% |
| 476 | Neoplasms, Unknown Primary | 3.3% |
| 477 | Leukemic Infiltration | 3.3% |
| 478 | Histiocytic sarcoma | 3.3% |
| 479 | Neoplasm Micrometastasis | 3.3% |
| 480 | Pheochromocytoma | 3.3% |
| 481 | Alveolar rhabdomyosarcoma | 3.3% |
| 482 | Hodgkin Disease | 2.9% |
| 483 | Lymphoma, Non-Hodgkin | 2.9% |
| 484 | Polycystic Ovary Syndrome | 2.9% |
| 485 | Xeroderma Pigmentosum | 2.8% |
| 486 | Adenocarcinoma | 2.7% |
| 487 | Carcinoma in Situ | 2.7% |
| 488 | Carcinoma, Transitional Cell | 2.7% |
| 489 | Phyllodes Tumor | 2.7% |
| 490 | Dysgerminoma | 2.7% |
| 491 | Hemangioendothelioma | 2.7% |
| 492 | Lipoma | 2.7% |
| 493 | Myoma | 2.7% |
| 494 | Myxoma | 2.7% |
| 495 | Neuroma | 2.7% |
| 496 | Papilloma | 2.7% |
| 497 | Pseudomyxoma Peritonei | 2.7% |
| 498 | Seminoma | 2.7% |
| 499 | Papillomatosis | 2.7% |
| 500 | Angiolipoma | 2.7% |
| 501 | Myelolipoma | 2.7% |
| 502 | Neoplasms, Bone Tissue | 2.7% |
| 503 | Neoplasms, Fibrous Tissue | 2.7% |
| 504 | Smooth Muscle Tumor | 2.7% |
| 505 | Adenomatosis, Pulmonary | 2.7% |
| 506 | Adenomatous Polyps | 2.7% |
| 507 | Carcinoma, Large Cell | 2.7% |
| 508 | Carcinoma, Small Cell | 2.7% |
| 509 | Desmoplastic Small Round Cell Tumor | 2.7% |
| 510 | Chondroma | 2.7% |
| 511 | Enchondroma | 2.7% |
| 512 | Primary amyloidosis | 2.6% |
| 513 | Leukemia, Myelomonocytic, Chronic | 2.3% |
| 514 | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 2.3% |
| 515 | Rift Valley Fever | 2.3% |
| 516 | Adenoid Cystic Carcinoma | 2.2% |
| 517 | fibroma | 2.2% |
| 518 | Fibromatosis | 2.2% |
| 519 | Osteoblastoma | 2.2% |
| 520 | Osteoma | 2.2% |
| 521 | Rhabdomyoma | 2.2% |
| 522 | Chondromatosis | 2.2% |
| 523 | Adenocarcinoma, Clear Cell | 2.2% |
| 524 | Cholangiocarcinoma | 2.2% |
| 525 | Cervical Intraepithelial Neoplasia | 2.2% |
| 526 | Hemangioblastoma | 2.2% |
| 527 | Lymphoma, Extranodal NK-T-Cell | 2.2% |
| 528 | Waldenstrom Macroglobulinemia | 2.1% |
| 529 | Multiple Myeloma | 2.1% |
| 530 | Mastocytosis | 2.1% |
| 531 | Sturge-Weber Syndrome | 2.1% |
| 532 | Cell Transformation, Viral | 2.1% |
| 533 | Hemangioma, Cavernous | 2.1% |
| 534 | Leukemia, T-Cell | 2% |
| 535 | Leukemia, B-Cell | 2% |
| 536 | neurofibroma | 2% |
| 537 | Lymphoma, Follicular | 2% |
| 538 | T-Cell Lymphoma | 2% |
| 539 | Mantle cell lymphoma | 2% |
| 540 | Fibromatosis, Aggressive | 1.9% |
| 541 | Fibromatosis, Abdominal | 1.9% |
| 542 | Klatskin Tumor | 1.9% |
| 543 | Mastocytoma | 1.9% |
| 544 | Mastocytosis, Systemic | 1.9% |
| 545 | Leukemia, Myeloid, Chronic-Phase | 1.9% |
| 546 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1.6% |
| 547 | Leukemia, Large Granular Lymphocytic | 1.6% |
| 548 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1.6% |
| 549 | Lymphoma, T-Cell, Cutaneous | 1.6% |
| 550 | Lymphoma, AIDS-Related | 1.6% |
| 551 | Enteropathy-Associated T-Cell Lymphoma | 1.6% |
| 552 | Primary Effusion Lymphoma | 1.6% |
| 553 | Dupuytren Contracture | 1.5% |
| 554 | Urticaria Pigmentosa | 1.4% |
| 555 | Mycosis Fungoides | 1.4% |
| 556 | Lymphomatoid Papulosis | 1.4% |
| 557 | Plasmablastic lymphoma | 1.4% |
| 558 | Burkitt Lymphoma | 1.3% |
| 559 | Sezary Syndrome | 1.1% |
| 560 | Radicular Cyst | 1.1% |